VNP.TO
5N Plus Inc. [VNP.TO] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VNP.TO Stock Summary
Top 10 Correlated ETFs
VNP.TO
Top 10 Correlated Stocks
VNP.TO
In the News
VNP.TO Financial details
Company Rating
Strong Buy
Market Cap
428.12M
Income
15.4M
Revenue
242.37M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
766
Optionable
No
Shortable
Yes
Earnings
31 Jul 2023
P/E
-67.89
Forward P/E
-
PEG
4.42
P/S
0.99
P/B
1.92
P/C
-
P/FCF
19.05
Quick Ratio
0.99
Current Ratio
2.38
Debt / Equity
1.08
LT Debt / Equity
0.87
-
-
EPS (TTM)
0.15
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
4.34%
Revenue Q/Q
3.36%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
25%
SMA100
66.67%
Inst Own
0.08%
Inst Trans
0.94%
ROA
-1%
ROE
-3%
ROC
0.03%
Gross Margin
23%
Oper. Margin
3%
Profit Margin
-1%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.86-5.13
52W High
-7%
52W Low
+132.5%
RSI
48
Rel Volume
0.28
Avg Volume
117.35K
Volume
32.69K
Perf Week
-6.25%
Perf Month
1.53%
Perf Quarter
41.34%
Perf Half Y
40.48%
-
-
-
-
Beta
1.54742
-
-
Volatility
0.06%, 0.2%
Prev Close
-2.52%
Price
4.65
Change
-1.06%
VNP.TO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.33 | 2.15 | 2.54 | 3.19 | 0 | |
| Net income per share | 0.02 | 0.03 | 0.04 | -0.28 | 0 | |
| Operating cash flow per share | 0.03 | 0.45 | 0.12 | 0.29 | 0 | |
| Free cash flow per share | -0.09 | 0.34 | 0.05 | 0.08 | 0 | |
| Cash per share | 0.24 | 0.48 | 0.43 | 0.52 | 0 | |
| Book value per share | 1.4 | 1.44 | 1.65 | 1.36 | 0 | |
| Tangible book value per share | 1.27 | 1.32 | 0.99 | 0.84 | 0 | |
| Share holders equity per share | 1.4 | 1.44 | 1.65 | 1.36 | 0 | |
| Interest debt per share | 0.78 | 0.71 | 1.84 | 1.89 | 0 | |
| Market cap | 158.93M | 191.02M | 154.6M | 177.77M | 0 | |
| Enterprise value | 200.21M | 206.54M | 267.3M | 286.48M | 103.93M | |
| P/E ratio | 89.04 | 87.39 | 49.71 | -7.73 | 0 | |
| Price to sales ratio | 0.81 | 1.08 | 0.74 | 0.67 | 0 | |
| POCF ratio | 59.28 | 5.19 | 15.05 | 7.49 | 0 | |
| PFCF ratio | -20.96 | 6.76 | 35.59 | 26.59 | 0 | |
| P/B Ratio | 1.35 | 1.61 | 1.13 | 1.58 | 0 | |
| PTB ratio | 1.35 | 1.61 | 1.13 | 1.58 | 0 | |
| EV to sales | 1.02 | 1.17 | 1.27 | 1.08 | 0.43 | |
| Enterprise value over EBITDA | 10.34 | 8.19 | 10.52 | 57.85 | 2.38 | |
| EV to operating cash flow | 74.68 | 5.61 | 26.03 | 12.07 | 6.02 | |
| EV to free cash flow | -26.41 | 7.31 | 61.53 | 42.85 | -104.77 | |
| Earnings yield | 0.01 | 0.01 | 0.02 | -0.13 | 0 | |
| Free cash flow yield | -0.05 | 0.15 | 0.03 | 0.04 | 0 | |
| Debt to equity | 0.52 | 0.47 | 1.09 | 1.34 | 1.08 | |
| Debt to assets | 0.27 | 0.24 | 0.4 | 0.44 | 0.4 | |
| Net debt to EBITDA | 2.13 | 0.62 | 4.44 | 21.95 | 2.38 | |
| Current ratio | 3.91 | 4.13 | 3.01 | 2.98 | 2.22 | |
| Interest coverage | 2.02 | 3.87 | 3.47 | -2.34 | 3.1 | |
| Income quality | 1.5 | 16.84 | 3.3 | -1.03 | 1.12 | |
| Dividend Yield | 0 | 0 | 0.46 | 0 | 0 | |
| Payout ratio | 0 | 0 | 22.83 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0 | |
| Intangibles to total assets | 0.05 | 0.04 | 0.15 | 0.12 | 0.12 | |
| Capex to operating cash flow | -3.83 | -0.23 | -0.58 | -0.72 | -1.06 | |
| Capex to revenue | -0.05 | -0.05 | -0.03 | -0.06 | -0.08 | |
| Capex to depreciation | -0.92 | -0.73 | -0.47 | -0.96 | -1.11 | |
| Stock based compensation to revenue | 0.01 | 0.02 | 0 | 0.01 | 0.01 | |
| Graham number | 0.82 | 0.93 | 1.18 | 2.92 | 0 | |
| ROIC | 0.02 | 0.02 | 0.01 | -0.05 | 0.08 | |
| Return on tangible assets | 0.01 | 0.01 | 0.01 | -0.08 | 0.05 | |
| Graham Net | -0.3 | -0.1 | -1.43 | -1.46 | 0 | |
| Working capital | 107.7M | 114.35M | 130.46M | 124.32M | 100.16M | |
| Tangible asset value | 106.31M | 108.71M | 81.93M | 69.39M | 87.46M | |
| Net current asset value | 32.07M | 42.59M | -41.82M | -48.05M | -39.65M | |
| Invested capital | 0.52 | 0.47 | 1.09 | 1.34 | 1.08 | |
| Average receivables | 30.89M | 34.73M | 41.35M | 42.76M | 36.73M | |
| Average payables | 19.72M | 14.86M | 22.07M | 23.25M | 16.09M | |
| Average inventory | 90.13M | 75.25M | 81.33M | 90.89M | 96.05M | |
| Days sales outstanding | 63.16 | 73.23 | 81.96 | 52.99 | 52.87 | |
| Days payables outstanding | 40.27 | 30.91 | 68.67 | 24.16 | 35.36 | |
| Days of inventory on hand | 188.75 | 174.04 | 203.65 | 145.95 | 209.03 | |
| Receivables turnover | 5.78 | 4.98 | 4.45 | 6.89 | 6.9 | |
| Payables turnover | 9.06 | 11.81 | 5.32 | 15.11 | 10.32 | |
| Inventory turnover | 1.93 | 2.1 | 1.79 | 2.5 | 1.75 | |
| ROE | 0.02 | 0.02 | 0.02 | -0.2 | 0.12 | |
| Capex per share | -0.12 | -0.1 | -0.07 | -0.21 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.69 | 0.62 | 0.66 | 0.71 | 0 | |
| Net income per share | -0.09 | 0.02 | 0.11 | 0.02 | 0 | |
| Operating cash flow per share | 0.15 | -0.04 | 0.13 | -0.02 | 0 | |
| Free cash flow per share | 0.11 | -0.09 | 0.08 | -0.05 | 0 | |
| Cash per share | 0.48 | 0.47 | 0.45 | 0.34 | 0 | |
| Book value per share | 1.28 | 1.29 | 1.39 | 1.41 | 0 | |
| Tangible book value per share | 0.79 | 0.81 | 0.92 | 0.95 | 0 | |
| Share holders equity per share | 1.28 | 1.29 | 1.39 | 1.41 | 0 | |
| Interest debt per share | 1.73 | 1.73 | 1.64 | 1.57 | 0 | |
| Market cap | 189.67M | 226.01M | 218.88M | 228.18M | 0 | |
| Enterprise value | 298.38M | 335.81M | 322.4M | 335.87M | 103.93M | |
| P/E ratio | -5.82 | 38.86 | 5.39 | 37.58 | 0 | |
| Price to sales ratio | 3.11 | 4.09 | 3.71 | 3.63 | 0 | |
| POCF ratio | 14.15 | -59.92 | 19.24 | -107.18 | 0 | |
| PFCF ratio | 20.44 | -29.52 | 31.88 | -47.31 | 0 | |
| P/B Ratio | 1.68 | 1.96 | 1.76 | 1.81 | 0 | |
| PTB ratio | 1.68 | 1.96 | 1.76 | 1.81 | 0 | |
| EV to sales | 4.89 | 6.07 | 5.46 | 5.34 | 1.6 | |
| Enterprise value over EBITDA | -76.63 | 37.95 | 18.52 | 35.7 | 12.73 | |
| EV to operating cash flow | 22.26 | -89.03 | 28.34 | -157.76 | 8.83 | |
| EV to free cash flow | 32.15 | -43.86 | 46.96 | -69.64 | 22.49 | |
| Earnings yield | -0.04 | 0.01 | 0.05 | 0.01 | 0 | |
| Free cash flow yield | 0.05 | -0.03 | 0.03 | -0.02 | 0 | |
| Debt to equity | 1.34 | 1.31 | 1.16 | 1.09 | 1.08 | |
| Debt to assets | 0.44 | 0.43 | 0.42 | 0.41 | 0.4 | |
| Net debt to EBITDA | -27.92 | 12.41 | 5.95 | 11.45 | 12.73 | |
| Current ratio | 2.98 | 2.22 | 2.38 | 2.34 | 2.22 | |
| Interest coverage | -8.3 | 2.09 | 6.18 | 2.25 | 1.9 | |
| Income quality | -1.65 | -2.59 | 1.12 | -1.4 | 5.15 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.06 | 0.02 | 0.02 | 0 | 0 | |
| Intangibles to total assets | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | |
| Capex to operating cash flow | -0.31 | 1.03 | -0.4 | 1.27 | -0.61 | |
| Capex to revenue | -0.07 | -0.07 | -0.08 | -0.04 | -0.11 | |
| Capex to depreciation | -1.02 | -0.94 | -1.11 | -0.67 | -1.74 | |
| Stock based compensation to revenue | 0.04 | 0.02 | 0 | 0.01 | 0.01 | |
| Graham number | 1.63 | 0.69 | 1.89 | 0.74 | 0 | |
| ROIC | -0.03 | 0.01 | 0.04 | 0.01 | 0.02 | |
| Return on tangible assets | -0.03 | 0 | 0.03 | 0.01 | 0.01 | |
| Graham Net | -1.37 | -1.32 | -1.14 | -1.15 | 0 | |
| Working capital | 124.32M | 103.27M | 105.4M | 103.55M | 100.16M | |
| Tangible asset value | 69.39M | 72.23M | 81.89M | 84.35M | 87.46M | |
| Net current asset value | -48.05M | -46.15M | -37.09M | -32.66M | -39.65M | |
| Invested capital | 1.34 | 1.31 | 1.16 | 1.09 | 1.08 | |
| Average receivables | 42.09M | 37.86M | 36.7M | 38.21M | 37.74M | |
| Average payables | 29.84M | 26.76M | 35.13M | 31.15M | 24.59M | |
| Average inventory | 88.04M | 90.5M | 97.58M | 101.38M | 104.1M | |
| Days sales outstanding | 56.56 | 60.82 | 54.92 | 57.72 | 48.57 | |
| Days payables outstanding | 26.83 | 84.09 | 65.29 | 55.87 | 32.44 | |
| Days of inventory on hand | 162.03 | 203.04 | 211.31 | 182.8 | 191.77 | |
| Receivables turnover | 1.59 | 1.48 | 1.64 | 1.56 | 1.85 | |
| Payables turnover | 3.35 | 1.07 | 1.38 | 1.61 | 2.77 | |
| Inventory turnover | 0.56 | 0.44 | 0.43 | 0.49 | 0.47 | |
| ROE | -0.07 | 0.01 | 0.08 | 0.01 | 0.02 | |
| Capex per share | -0.05 | -0.04 | -0.05 | -0.03 | 0 |
VNP.TO Frequently Asked Questions
What is 5N Plus Inc. stock symbol ?
5N Plus Inc. is a CA stock , located in Montreal of Qc and trading under the symbol VNP.TO
What is 5N Plus Inc. stock quote today ?
5N Plus Inc. stock price is $4.65 today.
Is 5N Plus Inc. stock public?
Yes, 5N Plus Inc. is a publicly traded company.
Company Profile
- Volume Average 117.35K
- Market Capitalization 428.12M
- Employee 766
- CEO Mr. Gervais Jacques
- Headquarters Montreal,QC,CA
- IPO Date 2007-12-20
-
Website
https://www.5nplus.com 
5N Plus Inc. produces and sells semiconductors in North America, Europe, and Asia. It operates through Specialty Semiconductors and Performance Material segments. The company offers low melting point alloys, semiconductor compounds and wafers, as well as various chemicals, and metals. It is also involved in manufacture of metallic powders for micro-electronic and manufacturing applications. In addition, the company is involved in animal feed additives and pharmaceutical ingredients as well as offers recycling services. The company serves renewable energy, security, space, pharmaceutical, medical imaging, manufacturing, electronic, consumer, and industrial applications.5N Plus Inc. is headquartered in Montreal, Canada.
